Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C34H37N5O5 |
Molecular Weight | 595.6881 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCCN1C(=O)[C@H](CC3=CC=CC=C3)N4C(=O)[C@](C)(NC(=O)[C@H]5CN(C)[C@]6([H])CC7=CN(C)C8=CC=CC(=C78)C6=C5)O[C@@]24O
InChI
InChIKey=SZUQJDJBJHBVBO-CTTKVJGISA-N
InChI=1S/C34H37N5O5/c1-33(32(42)39-27(15-20-9-5-4-6-10-20)31(41)38-14-8-13-28(38)34(39,43)44-33)35-30(40)22-16-24-23-11-7-12-25-29(23)21(18-36(25)2)17-26(24)37(3)19-22/h4-7,9-12,16,18,22,26-28,43H,8,13-15,17,19H2,1-3H3,(H,35,40)/t22-,26-,27+,28+,33-,34+/m1/s1
Molecular Formula | C34H37N5O5 |
Molecular Weight | 595.6881 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Metergotamine (MY-25 or 1-methyl-ergotamine-bitartrate) is a derivative of ergotamine and belongs to peptide alkaloids. It exerts a dampening effect on vessels, in that relaxation is brought about in contracted vessels, whereas contraction is brought in dilated vessels. Metergotamine was being studied in migraine prophylaxis.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:07:08 GMT 2023
by
admin
on
Fri Dec 15 19:07:08 GMT 2023
|
Record UNII |
V7O172Q572
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3356
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
DTXSID80176873
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
100000081222
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
C170167
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
65703
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106428
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
V7O172Q572
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
C018509
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
SUB08825MIG
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
22336-84-1
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |